Verition Fund Management LLC Abbott Laboratories Call Options Transaction History

Verition Fund Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $930,650 - $1.1 Million	-9,300 Reduced 16.29%	47,800 $5.45 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $2.53 Million - $2.82 Million	25,100 Added 78.44%	57,100 $5.93 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $3.13 Million - $3.46 Million	28,600 Added 841.18%	32,000 $3.64 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $27,057 - $33,120	300 Added 9.68%	3,400 $374,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $296,143 - $355,322	3,100 New	3,100 $300,000
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $1.03 Million - $1.25 Million	9,000 New	9,000 $1.07 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.